Eosinophilic myocarditis due to Churg-Strauss syndrome with markedly elevated eosinophil cationic protein

International Heart Journal

Volumn 54, Issue 1, 2013, Pages 51-53

  Hara, Tomoya ^a   Yamaguchi, Koji ^a   Iwase, Takashi ^a   Kadota, Muneyuki ^a   Bando, Mika ^a   Ogasawara, Kozue ^a   Bando, Sachiko ^a   Ise, Takayuki ^a   Niki, Toshiyuki ^a   Ueda, Yuka ^a   Tomita, Noriko ^a   Taketani, Yoshio ^a   Yamada, Hirotsugu ^a   Soeki, Takeshi ^a   Wakatsuki, Tetsuzo ^a   Sata, Masataka ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Heart failure; Inflammation

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CYCLOPHOSPHAMIDE; DIURETIC AGENT; EOSINOPHIL CATIONIC PROTEIN; GADOLINIUM; PREDNISOLONE; TROPONIN T;

AGED; ARTICLE; ASTHMA; CARDIOVASCULAR MAGNETIC RESONANCE; CASE REPORT; CHURG STRAUSS SYNDROME; CONTRAST ENHANCEMENT; DERMATITIS; DIFFUSE LEFT VENTRICULAR HYPOKINESIS; DYSPNEA; ECHOCARDIOGRAPHY; EDEMA; ELECTROCARDIOGRAM; EOSINOPHILIC MYOCARDITIS; FEMALE; HEART EDEMA; HEART LEFT VENTRICLE FAILURE; HOSPITAL DISCHARGE; HUMAN; HUMAN TISSUE; HYPEREOSINOPHILIA; LEUKOCYTOSIS; MYOCARDITIS; PARESTHESIA; PRIORITY JOURNAL; PURPURA; SKIN BIOPSY; THORAX RADIOGRAPHY; WHEEZING;

AGED; ASTHMA; BIOPSY; CHURG-STRAUSS SYNDROME; CYCLOPHOSPHAMIDE; DIURETICS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EOSINOPHIL GRANULE PROTEINS; EOSINOPHILIA; FEMALE; HEART FAILURE; HEART FUNCTION TESTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MAGNETIC RESONANCE IMAGING; MYOCARDITIS; PREDNISOLONE; PURPURA;

EID: 84874359235     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.54.51     Document Type: Article

References (10)

1. Guideline for management of vasculitis syndrome (JCS 2008). Circ J 2011; 75: 474-503.
2. Guidelines for diagnosis and treatment of myocarditis (JCS 2009). Circ J 2011; 75: 734-43.
3. Rothenberg ME. Eosinophilia. N Engl J Med 1998; 338: 1592-600. (Review)
4. Kawano S, Kato J, Kawano N, et al. Clinical features and outcomes of eosinophilic myocarditis patients treated with prednisolone at a single institution over a 27-year period. Intern Med 2011; 50: 975-81. (Review)
5. Ramakrishna G, Connolly HM, Tazelaar HD, Mullany CJ, Midthun DE. Churg-Strauss syndrome complicated by eosinophilic endomyocarditis. Mayo Clin Proc 2000; 75: 631-5. (Review)
6. Guillevin L, Lhote F, Gayraud M, et al. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore) 1996; 75: 17-28.
7. Tai PC, Ackerman SJ, Spry CJ, Dunnette S, Olsen EG, Gleich GJ. Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial disease. Lancet 1987; 21: 643-7.
8. Arima M, Kanoh T, Kawano Y, Oigawa T, Yamagami S, Matsuda S. Serum levels of eosinophil cationic protein in patients with eosinophilic myocarditis. Int J Cardiol 2002; 84: 97-9.
9. Kim CH, Vlietstra RE, Edwards WD, Reeder GS, Gleich GJ. Steroid-responsive eosinophilic myocarditis: diagnosis by endomyocardial biopsy. Am J Cardiol 1984; 53: 1472-3.
10. Cooper LT, Zehr KJ. Biventricular assist device placement and immunosuppression as therapy for necrotizing eosinophilic myocarditis. Nat Clin Pract Cardiovasc Med 2005; 2: 544-8.